218PAutoimmunity and benefit from trastuzumab treatment in breast cancer: Results from the HERA phase III trial. (23rd October 2018) - Sonnenblick, A; Bailey, A; Uziely, B; Untch, M; Smith, I; Gianni, L; Baselga, J; Jackisch, C; Cameron, D; Bell, R; Zardavas, D; Al-Sakaff, N; et al.